Načítá se...
Informing patients about their mutation tests: CDKN2A c.256G>A in melanoma as an example
BACKGROUND: When germline mutations are suspected as causal in cancer, patient DNA may be sequenced to detect variants in relevant genes. If a particular mutation has not been reported in reliable family studies, genetic counselors are facing a dilemma of appropriately informing patients. Many seque...
Uloženo v:
| Vydáno v: | Hered Cancer Clin Pract |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7393828/ https://ncbi.nlm.nih.gov/pubmed/32760473 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13053-020-00146-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|